News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians
Razan Mohty/X
Mar 4, 2025, 04:35

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Razan Mohty, Assistant Professor at UAB Medicine, shared a paper she and her colleagues authored on X:

“Happy to share our recent manuscript on outcomes of anti-CD19 CART for lymphoma in octogenarians (80 years of age or older).

– CR rate 71.4%
– 1-year OS 61.2%
– 1-year PFS 47.6%
– 1-year NRM 11.6%

Thanks to all collaborators.”

Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study

Authors: Mohamed A. Kharfan-Dabaja, Razan Mohty et al.

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Aaron P. Rapoport Amer Beitinjaneh Amitkumar Mehta Arushi Khurana Bhagirathbhai Dholaria cancer Deepa Jagadeesh Ernesto Ayala Forat Lutfi Frederick L. Locke Javier Munoz Jean Yared Jennifer Logue Jose Sandoval-Sus Joseph McGuirk Joshua Fein Julio C. Chavez Kaitlin Annunzio Lazaros Lekakis Madiha Iqbal Mayur Narkhede Mehdi Hamadani Michael D. Jain Mohamed A. Kharfan-Dabaja Muhamad Alhaj-Moustafa Narendranath Epperla Nausheen Ahmed Neela Easwar Olalekan O. Oluwole OncoDaily Oncology Othman Salim Akhtar Patrick Johnston Praveen Ramakrishnan Geethakumari Razan Mohty Samuel Yamshon Tsiporah Shore Urshila Durani Usama Gergis Yi Lin
Special Coverage
Blog
Mar 4, 2025, 04:35
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians
Blog
Mar 4, 2025, 04:35
Recommendations and best practices to boost vaccination and prevent HPV cancers - ECO
Science
Mar 3, 2025, 15:58
Esranur Aydın: Metastatic IDH2-mutant cholangiocarcinoma treated with venetoclax and decitabine
Science
Mar 3, 2025, 15:56
Selpercatinib in RET Fusion-Positive NSCLC by Oliver Gautschi et al.
Blog
Mar 3, 2025, 15:54
Jihan Azar: Childhood Cancer Inequalities in the WHO Eastern Mediterranean Region
Insight
Mar 3, 2025, 15:53
Arthur Sun Myint: Beacon of hope for patients with rectal cancer wishing to avoid major surgery and a stoma
Blog
Mar 3, 2025, 15:53
Toufic Kachaamy: Aasma Shaukat on how AI might accelerate precision medicine initiatives for CRC prevention
Blog
Mar 3, 2025, 15:52
Magdalena Skipper: An assault of science and scientists anywhere is an assault on science and scientists everywhere
Science
Mar 3, 2025, 15:51
Patrick Hwu: Are B cells important to eliminate cancers?
Blog
Mar 3, 2025, 15:50
Wafaa Rashed: Honored to feature Dr. Mary Relling in PAPERI Bright Minds Series episode
Blog
Mar 3, 2025, 15:49
Wafik El-Deiry: Discussing Legorreta Cancer Center's programmatic leadership
Blog
Mar 3, 2025, 15:48
Registration is open for the ASCO-Endorsed CPOEM Foundation Webinar